PET/CT
PET/CT is a medical procedure with 129 clinical trials. Currently 26 active trials ongoing. Historical success rate of 74.1%.
Success Metrics
Based on 43 completed trials
Phase Distribution
Phase Distribution
25
Early Stage
20
Mid Stage
5
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
71.7%
43 of 60 finished
28.3%
17 ended early
26
trials recruiting
129
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Detection and Outcomes in Metastatic Invasive Lobular Breast Cancer Through Novel F-18 FAP PET
A Pilot Study to Correlate 4-18F- Fluoro-1-naphthol 18F-4FN PET/CT Imaging With Chronic Graft Versus Host Disease Manifestations
A Study of 177Lu-DTPA-SC16.56 in People With Neuroendocrine Carcinomas of the Lung and Prostate
Imaging of Endometriosis With Total-body PET-CT (PET-Endo)
Augmented Whole-body Scanning Via Magnifying PET/CT (AWSM-PET/CT) Techniques Abilities to Improve Upon the Diagnostic Accuracy of the Standard-of-care (SOC) PET/CT for Malignant Lesion Detection
Clinical Trials (129)
Detection and Outcomes in Metastatic Invasive Lobular Breast Cancer Through Novel F-18 FAP PET
A Pilot Study to Correlate 4-18F- Fluoro-1-naphthol 18F-4FN PET/CT Imaging With Chronic Graft Versus Host Disease Manifestations
A Study of 177Lu-DTPA-SC16.56 in People With Neuroendocrine Carcinomas of the Lung and Prostate
Imaging of Endometriosis With Total-body PET-CT (PET-Endo)
Augmented Whole-body Scanning Via Magnifying PET/CT (AWSM-PET/CT) Techniques Abilities to Improve Upon the Diagnostic Accuracy of the Standard-of-care (SOC) PET/CT for Malignant Lesion Detection
Biopsy After Radioembolization to Identify Changes in Tumor Cells From the Radiation
18Fluorine-Fluciclovine PET/CT for Staging Muscle Invasive Bladder Cancer Preceding Radical Cystectomy
CCR2 PET for Pancreatic Cancer Imaging and Prediction of Response to Standard and CCR2-Targeted Therapy
Novel PET/CT and Treatment Strategies to Reduce PTS Following DVT
Synthetic PET From CT Improves Precision Diagnosis and Treatment of Lung Cancer: a Prospective, Observational, Multicenter Study
PSMAtrack-tracking Changes in PSMA-PET During Initial Therapy for Metastatic Hormone-sensitive Prostate Cancer
Pilot Study for Detection of PSMA-Low CRPC-NE Tumors With Fluciclovine PET/CT
DNA Sequencing-Based Monitoring of Minimal Residual Disease to Predict Clinical Relapse in Aggressive B-cell Non-Hodgkin Lymphomas
Improved Diagnostics and Monitoring of Polymyalgia Rheumatica
The Scottish Aortic Stenosis LongiTudinal Imaging and biomarkeR (SALTIRE) Programme
Study of PRRT in Metastatic, World Health Organization (WHO) Grade 1 or 2, SSTR Positive, GEP-NET Who Are Candidates for Cytoreductive Surgery
[18F]FLT PET/CT in Rb+ Metastatic Breast Cancer
Characterization of Abdomino-pelvic Lesions by 18Fluorine- Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography
Intensified Treatment With Carfilzomib in Myeloma Patients Still PET-positive After First Line Treatment.
68Ga-DOTATATE PET-CT for Diagnosis of Neuroendocrine Tumors (NETs)
Drug Details
- Intervention Type
- PROCEDURE
- Total Trials
- 129